Submitted by Anonymous (not verified) on 12 May 2026 - 16:25
Human medicines European public assessment report (EPAR): Sotyktu, deucravacitinib, Date of authorisation: 24/03/2023, Revision: 5, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Sotyktu, deucravacitinib, Date of authorisation: 24/03/2023, Revision: 5, Status: Authorised